Work

Thu0078 Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 7 Years: an Updated Integrated Safety Analysis

Year: 2019

Type: article

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2019-eular.691

Authors: Mark C. Genovese, Josef S. Smolen, Tsutomu Takeuchi, Gerd Rüdiger Burmester, Dennis Brinker, Terence Rooney, Jinglin Zhong, Daojun Mo, Chadi Saifan, Anabela Cardoso, Maher Issa, Wen-Shuo Wu, Kevin Winthrop

Institutions: Stanford Medicine, Medical University of Vienna, Keio University, Charité – Universitätsmedizin Berlin, Eli Lilly (United States), IQVIA (United States), Oregon Health & Science University

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, Karolinska Institutet

OpenAlex ID: W2950926826

FWCI: 4.564

Cites: 1

Cited by: 28

Related to: 10